CLASS II ONGOING Device recall · Reported 22 Mar 2023 · FDA Enforcement Report

Amicus Exchange Kit Therapeutics recalled by Fenwal

Fenwal is recalling Amicus Exchange Kit Therapeutics, distributed nationwide in the US. The recall was initiated on 14 Feb 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesProduct Code X6R2349; UDI: 04086000101950; Batch Numbers: FA22E23138, FA22F28168, FA22G28018, FA22H22225, FA22J28062, FA22K21065. The Lot number coding system is the following: FAXXYaabbc; FA = Haina (manufacturing / production unit); XX = two digit year; Y= letter of the alphabet corresponding to the month; aa= day; bb= sequential number; c= check digit.
Quantity recalled6,564 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1255-2023
FDA event ID
91704
Recalling firm
Fenwal, Lake Zurich, IL
Classification
Class II
Status
Ongoing
Recall initiated
14 Feb 2023
FDA classified
15 Mar 2023
Reported
22 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

14 Feb 2023Recall initiated by company
15 Mar 2023Classified by FDA+29 days
22 Mar 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Amicus Exchange Kit Therapeutics. Component of Amicus Separator multiprocedural apheresis platform

Where it was distributed

Nationwide distribution. International distribution to France, Korea, Taiwan, Colombia, India, Brazil, Germany, Canada.

Nationwide

Questions about this recall

Is Amicus Exchange Kit Therapeutics recalled?

Yes. Fenwal recalled Amicus Exchange Kit Therapeutics on 14 Feb 2023. The recall is Class II and its status is Ongoing. Recall number Z-1255-2023.

Why was it recalled?

Potential for centrifuge packs to develop a stress leak for certain lots of Amicus MNC Apheresis kit and Amicus Exchange kit (Therapeutic Kits) on the Amicus Separator.

Which lots are affected?

Product Code X6R2349; UDI: 04086000101950; Batch Numbers: FA22E23138, FA22F28168, FA22G28018, FA22H22225, FA22J28062, FA22K21065. The Lot number coding system is the following: FAXXYaabbc; FA = Haina (manufacturing / production unit); XX = two digit year; Y= letter of the alphabet corresponding to the month; aa= day; bb= sequential number; c= check digit.

Where was it sold?

Nationwide distribution. International distribution to France, Korea, Taiwan, Colombia, India, Brazil, Germany, Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fenwal

All 10

Other Other Medical Devices recalls

All 13,778